Company Filing History:
3 out of 5 
2 out of 41 
1 out of 3,381 
Years Active: 2007-2019
Title: Amy Lynn Allan: Innovator in Neurological Treatments
Introduction
Amy Lynn Allan is a prominent inventor based in Encinitas, CA (US). She has made significant contributions to the field of neuroscience through her innovative research and development of compounds aimed at treating various neurological disorders. With a total of 5 patents, her work has the potential to impact the lives of many individuals suffering from cognitive and motor deficits.
Latest Patents
Among her latest patents is the invention of substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitors. This invention provides a chemical entity of Formula (I), wherein R, R, R, and R have any of the values described herein. The invention includes compositions comprising such chemical entities, methods of making them, and their use in a wide range of applications. These applications include metabolic and reaction kinetic studies, detection and imaging techniques, and treatments for disorders mediated by PDE2 activity. Her work also addresses neurological disorders, CNS disorders, dementia, neurodegenerative diseases, and trauma-dependent losses of function. Furthermore, it focuses on treating stroke, enhancing cognitive and motor training efficiency, and facilitating neuroprotection and neurorecovery.
Another significant patent involves substituted pyrido[3,2-e][1,2,4]triazolo[1,5-c]pyrimidines and pyrido[2,3-e][1,2,4]triazolo[1,5-c]pyrimidines for the treatment of central nervous system diseases and disorders. This patent describes compounds and chemical entities of Formula (I), methods of their synthesis, and their use in treating cognitive deficits associated with CNS diseases and disorders.
Career Highlights
Amy has worked with notable companies such as Attenuon, LLC and Dart Neuroscience Ltd. Her experience in these organizations has allowed her to collaborate with other experts in the field and further her research endeavors.
Collaborations
Some of her notable coworkers include Robert J Ternansky and Andrew P Mazar. Their collaboration has contributed to the advancement of her research and the development of innovative treatments.
Conclusion
Amy Lynn Allan is a trailblazer in the field of neuroscience, with a focus on developing innovative treatments for neurological disorders. Her patents and collaborations